RNA-binding protein HuR interacts with thrombomodulin 5′untranslated region and represses internal ribosome entry site-mediated translation under IL-1β treatment

Molecular Biology of the Cell

Volumn 19, Issue 9, 2008, Pages 3812-3822

  Yeh, Chiu Hung ^a   Hung, Liang Yi ^a   Hsu, Chin ^c   Le, Shu Yun ^e   Lee, Pin Tse ^b   Liao, Wan Lin ^a   Lin, Yi Tseng ^d   Chang, Wen Chang ^a   Tseng, Joseph T ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; RNA BINDING PROTEIN; RNA BINDING PROTEIN HUR; THROMBOMODULIN; THROMBOMODULIN 5; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME; SEPSIS;

5' UNTRANSLATED REGIONS; ANIMALS; ANTIGENS, SURFACE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; MODELS, BIOLOGICAL; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA; RNA-BINDING PROTEINS; SEPSIS; THROMBOMODULIN;

ANIMALIA;

EID: 55549131174     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-09-0962     Document Type: Article

References (48)

1. Abeyama, K. et al. (2005). The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115, 1267-1274.
2. Archipoff, G., Beretz, A., Freyssinet, J. M., Klein-Soyer, C., Brisson, C., and Cazenave, J. P. (1991). Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem. J. 273, 679-684.
3. Atasoy, U., Curry, S. L., Lopez de Silanes, I., Shyu, A. B., Casolaro, V., Gorospe, M., and Stellato, C. (2003). Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J. Immunol. 171, 4369-4378.
4. Baird, S. D., Turcotte, M., Korneluk, R. G., and Holcik, M. (2006). Searching for IRES. RNA 12, 1755-1785.
5. Brennan, C. M., and Steitz, J. A. (2001). HuR and mRNA stability. Cell Mol. Life Sci. 58, 266-277.
6. Campbell, W. D., Lazoura, E., Okada, N., and Okada, H. (2002). Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46, 131-134.
7. Conway, E. M., and Rosenberg, R. D. (1988). Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell. Biol. 8, 5588-5592.
8. Conway, E. M. et al. (2002). The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J. Exp. Med. 196, 565-577.
9. Diehl, J. L., and Borgel, D. (2005). Sepsis and coagulation. Curr. Opin. Crit. Care 11, 454-460.
10. Dittman, W. A., and Majerus, P. W. (1990). Structure and function of thrombomodulin: a natural anticoagulant. Blood 75, 329-336.
11. Esmon, C. T. (1993). Molecular events that control the protein C anticoagulant pathway. Thromb. Haemost. 70, 29-35.
12. Esmon, C. T. (2005). The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417-430.
13. Faust, S. N., Levin, M., Harrison, O. B., Goldin, R. D., Lockhart, M. S., Kondaveeti, S., Laszik, Z., Esmon, C. T., and Heyderman, R. S. (2001). Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N. Engl. J. Med. 345, 408-416.
14. Galban, S., Martindale, J. L., Mazan-Mamczarz, K., López de Silanes, I., Fan, J., Wang, W., Decker, J., and Gorospe, M. (2003). Influence of the RNAbinding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol. Cell. Biol. 23, 7083-7095.
15. Gray, N., and Wickens, M. (1998). Control of translation initiation in animals. Annu. Rev. Cell Dev. Biol. 14, 399-458.
16. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730.
17. Haley, M., Cui, X., Minneci, P. C., Deans, K. J., Natanson, C., and Eichacker, P. Q. (2004). Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness. Curr. Opin. Infect. Dis. 17, 205-211.
18. Hsieh, Y. C., Hsu, C., Yang, R. C., Lee, P. Y., Hsu, H. K., and Sun, Y. M. (2004). Isolation of bona fide differentially expressed genes in the 18-hour sepsis liver by suppression subtractive hybridization. Shock 21, 549-555.
19. Ideker, T., Thorsson, V., and Ranish, J. A. (2001). Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292, 929-934.
20. Katsanou, V., Papadaki, O., Milatos, S., Blackshear, P. J., Anderson, P., Kollias, G., and Kontoyiannis, D. L. (2005). HuR as a negative posttranscriptional modulator in inflammation. Mol. Cell 19, 777-789.
21. Kozak, M. (1986). Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 83, 2850-2854.
22. Kullmann, M., Gopfert, U., Siewe, B., and Hengst, L. (2002). ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev. 16, 3087-3099.
23. Kume, M., Hayashi, T., Yuasa, H., Tanaka, H., Nishioka, J., Ido, M., Gabazza, E. C., Kawarada, Y., and Suzuki, K. (2003). Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats - a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J. Hepatol. 38, 9-17.
24. Lang, K. J., Kappel, A., and Goodall, G. J. (2002). Hypoxia-inducibile factor-1 alpha mRNA contains an internal ribosome entry site that allows efficiency translation during normoxia and hypoxia. Mol. Biol. Cell 13, 1792-1801.
25. Le, S. Y., and Maizel, J. V. (1997). A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucl. Acid Res. 25, 362-369.
26. Leandersson, K., Riesbeck, K., and Andersson, T. (2006). Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res. 34, 3988-3999.
27. Lentz, S. R., Tsiang, M., and Sadler, J. E. (1991). Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood 77, 542-550.
28. Levi, M., and Van der Poll, T. (2005). Two-way interactions between inflammation and coagulation. Trends Cardiovasc. Med. 15, 254-259.
29. Linker, K., Pautz, A., Fechir, M., Hubrich, T., Greeve, J., and Kleinert, H. (2005). Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 33, 4813-4827.
30. Mathews, D. H., Sabina, J., Zuker, M., and Turner, D. H. (1999). Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288, 911-940.
31. Meisner, N. C. et al. (2007). Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat. Chem. Biol. 3, 508-515.
32. Meng, Z., King, P. H., Nabors, L. B., Jackson, N. L., Chen, C. Y., Emanuel, P. D., and Blume, S. W. (2005). The ELAV RNA-stability factor HuR binds the 5′-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation. Nucleic Acids Res. 33, 2962-2979.
33. Moore, K. L., Andreoli, S. P., Esmon, N. L., Esmon, C. T., and Bang, N. U. (1987). Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79, 124-130.
34. Moore, K. L., Esmon, C. T., and Esmon, N. L. (1989). Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73, 159-165.
35. Okajima, K. (2001). Regulation of inflammatory responses by natural anticoagulants. Immunol. Rev. 184, 258-274.
36. Pelletier, J., and Sonenberg, N. (1988). Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320-325.
37. Pickering, B. M., and Willis, A. E. (2005). The implications of structured 5′ untranslated regions on translation and disease. Semin. Cell Dev. Biol. 16, 39-47.
38. Pilipenko, E. V., Pestova, T. V., Kolupaeva, V. G., Khitrina, E. V., Poperechnaya, A. N., Agol, V. I., and Hellen, C. U. (2000). A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 14, 2028-2045.
39. Rajasingh, J., Bord, E., Luedemann, C., Asai, J., Hamada, H., Thorne, T., Qin, G., Goukassian, D., Zhu, Y., Losordo, D. W., and Kishore, R. (2006). IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 20, 2112-2114.
40. Stoneley, M., Paulin, F. E., Le Quesne, J. P., Chappell, S. A., and Willis, A. E. (1998). c-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene 16, 423-428.
41. Stoneley, M., and Willis, A. E. (2004). Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23, 3200-3207.
42. Sureban, S. M., Murmu, N., Rodriguez, P., May, R., Maheshwari, R., Dieckgraefe, B. K., Houchen, C. W., and Anant, S. (2007). Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology 132, 1055-1065.
43. Van de Wouwer, M., and Conway, E. M. (2004). Novel functions of thrombomodulin in inflammation. Crit. Care Med. 32, S254-S261.
44. Vanger, S., Galy, B., and Pyronnet, S. (2001). Irresistible IRES. EMBO rep. 2, 893-898.
45. Vanger, S., Gensac, M. C., Maret, A., Bayard, F., Amalric, F., Prats, H., and Prats, A. C. (1995). Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15, 35-44.
46. Weiler, H., and Isermann, B. H. (2003). Thrombomodulin. J. Thromb. Haemost. 1, 1515-1524.
47. Wichterman, K. A., Baue, A. E., and Chaudry, I. H. (1980). Sepsis and septic shock-a review of laboratory models and a proposal. J. Surg. Res. 29, 189-201.
48. Yang, D. Q., Halaby, M. J., and Zhang, Y. (2006). The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25, 4613-4619.